(Q42694138)

5 November 2017

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis (English)

1 reference

5 November 2017

0 references

1 reference

1 reference

M J Elliott

1

1 reference

5 November 2017

R N Maini

2

1 reference

5 November 2017

M Feldmann

3

1 reference

5 November 2017

A Long-Fox

4

1 reference

5 November 2017

P Charles

5

1 reference

5 November 2017

H Bijl

6

1 reference

5 November 2017

J N Woody

7

1 reference

5 November 2017

language of work or name

English

0 references

publication date

1 October 1994

1 reference

5 November 2017

1 reference

5 November 2017

344

1 reference

5 November 2017

1125-1127

1 reference

5 November 2017

8930

1 reference

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

5 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990632-7

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990632-7

7 January 2021

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990632-7

7 January 2021

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990632-7

7 January 2021

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990632-7

7 January 2021

New directions for biological therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990632-7

7 January 2021

Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990632-7

7 January 2021

10.1016/S0140-6736(94)90632-7

Identifiers

DOI

1 reference

5 November 2017

1 reference